OpportunityTitle: Biosignature Discovery for Personalized Treatment in Depression (U01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Description: Purpose. The purpose of this initiative is to support exploratory research to discover panels of promising biomarkers (i.e., biosignatures) that are predictive of treatment outcomes in major depressive disorder. Mechanism of Support: This FOA will utilize the NIH Cooperative Agreement (U01) award mechanism. Funds Available and Anticipated Number of Awards: The NIMH expects to commit approximately $6 million in total costs in Fiscal Year 2010 to fund one or more U01 awards under this initiative.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;